COVID-19 in blood cancer patients
Part of Blood & lymphatic, Cancer, Infections clinical trials.
This study looks at COVID-19 in people who have (or have had) blood cancers and are positive for SARS‑CoV‑2. It may help doctors understand how COVID-19 affects people with blood cancers and guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a blood cancer history or a current blood cancer (examples: leukemia, lymphoma, myeloma).
- Your blood cancer is still active, or it has been diagnosed in the past.
- You have a confirmed positive COVID-19 test using an RT‑PCR test (from nose swab, lung fluid, or stool).
- You do not have a blood disease that is not a cancer (for example, a non-cancer blood condition).
- Your COVID test must be positive (not negative or unknown).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study looks at people with thalassemia, sickle cell disease, or other inherited anemia who have COVID-19. It aims to learn how COVID affects these conditions and may help improve care planning.
This study looks at how COVID-19 changes your genes, which might explain why some people have long-lasting symptoms. If you join, you'll provide a blood sample, and the results could help us better understand long COVID.
This trial collects and studies COVID-19 test results and other patient information to better predict treatment response and outcomes. Your sample(s) help researchers understand who may improve, worsen, or need different care.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This study looks at how the COVID-19 pandemic affected the experiences of teenagers and young adults with cancer, including people who finished treatment. It may help improve support for cancer patients and survivors during public health crises.
This study asks adult cancer patients to complete a survey and talk in an interview about how COVID-19 affected their care and daily life. Your answers may help researchers understand what challenges cancer patients faced during the pandemic.
Hear when a new COVID-19 Infection in Hematological Malignancies Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.